FI971227L - Pyramidinyylipyratsolijohdannaisia - Google Patents

Pyramidinyylipyratsolijohdannaisia Download PDF

Info

Publication number
FI971227L
FI971227L FI971227A FI971227A FI971227L FI 971227 L FI971227 L FI 971227L FI 971227 A FI971227 A FI 971227A FI 971227 A FI971227 A FI 971227A FI 971227 L FI971227 L FI 971227L
Authority
FI
Finland
Prior art keywords
pyramidinylpyrazole
derivatives
pyramidinylpyrazole derivatives
Prior art date
Application number
FI971227A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI971227A0 (fi
FI971227A7 (fi
Inventor
Akio Ejima
Masamichi Sugimori
Ikuo Mitsui
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of FI971227A0 publication Critical patent/FI971227A0/fi
Publication of FI971227A7 publication Critical patent/FI971227A7/fi
Publication of FI971227L publication Critical patent/FI971227L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI971227A 1994-09-26 1995-09-25 Pyramidinyylipyratsolijohdannaisia FI971227L (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP22942294 1994-09-26
JP13501095 1995-06-01
PCT/JP1995/001934 WO1996010024A1 (fr) 1994-09-26 1995-09-25 Derive pyrimidinylpyrazole

Publications (3)

Publication Number Publication Date
FI971227A0 FI971227A0 (fi) 1997-03-24
FI971227A7 FI971227A7 (fi) 1997-05-23
FI971227L true FI971227L (fi) 1997-05-23

Family

ID=26468965

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971227A FI971227L (fi) 1994-09-26 1995-09-25 Pyramidinyylipyratsolijohdannaisia

Country Status (13)

Country Link
US (1) US5852019A (forum.php)
EP (1) EP0784055B1 (forum.php)
KR (1) KR100388568B1 (forum.php)
CN (1) CN1071754C (forum.php)
AT (1) ATE232528T1 (forum.php)
CA (1) CA2201110A1 (forum.php)
DE (2) DE69529619T4 (forum.php)
DK (1) DK0784055T3 (forum.php)
ES (1) ES2192584T3 (forum.php)
FI (1) FI971227L (forum.php)
NO (1) NO313196B1 (forum.php)
TW (1) TW312694B (forum.php)
WO (1) WO1996010024A1 (forum.php)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1105707C (zh) * 1997-01-27 2003-04-16 第一制药株式会社 吡唑衍生物
US6169086B1 (en) 1997-01-27 2001-01-02 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivatives
WO2000005230A1 (fr) * 1998-07-24 2000-02-03 Daiichi Pharmaceutical Co., Ltd. Derives de pyrazole et sels correspondants
WO2000043385A1 (fr) * 1999-01-25 2000-07-27 Zenyaku Kogyo Kabushiki Kaisha Composes heterocycliques et agents antitumoraux les comprenant en tant que principe actif
AU2002253619B2 (en) * 2001-04-27 2007-05-17 Zenyaku Kogyo Kabushiki Kaisha Heterocyclic compound and antitumor agent containing the same active ingredients
WO2003011837A1 (en) * 2001-08-01 2003-02-13 Merck & Co., Inc. Tyrosine kinase inhibitors
EP1590329A1 (fr) * 2003-01-28 2005-11-02 Aventis Pharma S.A. Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation
US20050130989A1 (en) * 2003-01-28 2005-06-16 Aventis Pharma S. A. N-arylheteroaromatic products compositions containing them and use thereof
FR2850379B1 (fr) * 2003-01-28 2006-11-17 Aventis Pharma Sa Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation
US7223759B2 (en) * 2003-09-15 2007-05-29 Anadys Pharmaceuticals, Inc. Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds
DK1741714T3 (da) 2004-03-31 2013-04-15 Zenyaku Kogyo Kk Heterocyklisk forbindelse og middel mod ondartet turmor, der indeholder denne som aktiv ingrediens
JP5089377B2 (ja) 2005-03-11 2012-12-05 全薬工業株式会社 複素環式化合物を有効成分とする免疫抑制剤及び抗腫瘍剤
US20070244110A1 (en) * 2006-04-14 2007-10-18 Zenyaku Kogyo Kabushiki Kaisha Treatment of prostate cancer, melanoma or hepatic cancer
CA2675511A1 (en) 2006-10-10 2008-04-17 Amgen Inc. N-aryl pyrazole compounds for use against diabetes
US10287269B2 (en) * 2015-03-26 2019-05-14 Merck Sharp & Dohme Corp. Pyrazolyl pyrimidinone compounds as PDE2 inhibitors
ES2969565T3 (es) 2015-09-30 2024-12-13 Max Planck Ges Zur Foerderung Derwissenschaften E V Derivados heteroarílicos como inhibidores de la sepiapterina reductasa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3778433A (en) * 1969-04-18 1973-12-11 Sumitomo Chemical Co Process for producing benzodiazepine derivatives
JPS4842072A (forum.php) * 1971-09-29 1973-06-19
JPS61129129A (ja) * 1984-11-28 1986-06-17 Kureha Chem Ind Co Ltd 抗腫瘍剤
US5102893A (en) * 1986-07-07 1992-04-07 Warner-Lambert Company Trans-6-(2-(n-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl- or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis

Also Published As

Publication number Publication date
EP0784055A4 (en) 1998-01-07
ES2192584T3 (es) 2003-10-16
CN1166833A (zh) 1997-12-03
NO971384D0 (no) 1997-03-24
TW312694B (forum.php) 1997-08-11
KR970706275A (ko) 1997-11-03
HK1001396A1 (en) 1998-06-19
DK0784055T3 (da) 2003-06-02
NO313196B1 (no) 2002-08-26
DE69529619T2 (de) 2003-12-18
FI971227A0 (fi) 1997-03-24
KR100388568B1 (ko) 2003-10-04
FI971227A7 (fi) 1997-05-23
NO971384L (no) 1997-05-23
WO1996010024A1 (fr) 1996-04-04
CA2201110A1 (en) 1996-04-04
ATE232528T1 (de) 2003-02-15
EP0784055A1 (en) 1997-07-16
US5852019A (en) 1998-12-22
DE69529619D1 (en) 2003-03-20
CN1071754C (zh) 2001-09-26
EP0784055B1 (en) 2003-02-12
DE69529619T4 (de) 2005-01-27

Similar Documents

Publication Publication Date Title
FI954829L (fi) Aroyylipiperidiinijohdannaiset
NO952854D0 (no) 1-arylpyrimidin-derivater
DE59508427D1 (de) 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate
DK0901474T3 (da) Arylpyrimidinderivater
ATE261942T1 (de) 6-phenylpyridinderivate
NO981946D0 (no) Imidazoquinazolin-derivater
EP0708091A3 (en) Indoloyl-guanidines derivatives
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
DE69430587D1 (de) Pyrimidin-acyclonukleosid-derivate
BR9509793A (pt) Derivados de tiofeneno
FI971227L (fi) Pyramidinyylipyratsolijohdannaisia
FI960367L (fi) Uusia dialkoksipyridinyylibentsimidatsolijohdannaisia
EE9900182A (et) 2-metoksüfenüülpiperasiini derivaadid
DE69527786D1 (de) Diaminomethyliden-derivate
FI964853A7 (fi) Deasetoksitaksolijohdannaiset
NO970144L (no) Trifluormetylkinolinkarboksylsyre-derivat
DE69510792D1 (de) Naphtochinonderivate
DE59509209D1 (de) Diphenyloxazolin-derivate
FI955026L (fi) Alkyyli-5-metyylisulfonyylibentsoyyliguanidiinijohdannaisia
BR9509877A (pt) Novos derivados de pirimidinilóxi-e piridimidinilamino- etilfenil-dioxolano
FI965181A7 (fi) Polyalkoholi-peptidijohdannaiset
FI963122A7 (fi) Karbamoyylimetyyliureajohdannaiset
BR9506613A (pt) Derivados de feniltio-oxazolinas
BR9508450A (pt) Derivados de n-alcóxi-amidina
DE69427775D1 (de) Dimethylfurancarboxamilid-derivat